Baku 12° C
Oxford COVID vaccine to be tested on children for first time
Health
- 13 February, 2021
- 12:18
Add Report.az to preferred Google sources
Stay up to date with the top news!
The University of Oxford has launched a study to assess the safety and immune response of the COVID vaccine it has developed with AstraZeneca Plc in children for the first time, Report informs referring to Reuters.
The new mid-stage trial will determine whether the vaccine is effective for people between the ages of 6 and 17.
Around 300 volunteers will be enrolled, and the first vaccinations are expected this month.
The two-dose Oxford/AstraZeneca vaccine has been hailed as a 'vaccine for the world' because it is cheaper and easier to distribute than some rivals.
AstraZeneca aims to produce 3 billion doses this year and aims to make over 200 million doses per month by April.
Author
COVID-19 əleyhinə peyvənd ilk dəfə uşaqlar üzərində sınanacaq
Оксфордская вакцина от СOVID-19 будет впервые протестирована на детях
Latest News
15:34
Unsettled weather to persist in Azerbaijan until November 10, weather service warns
Ecology
15:21
Azerbaijan mulls expanding trade ties with Suriname
Business
15:10
MiniBoss Business School opens enrollment at its second Baku branch
Business
15:08
Lithuanian foreign minister meets Azerbaijani presidential adviser in Vilnius
Foreign policy
15:00
Fox News: US considers November 9 favorable day to resume strikes on Iran
Other countries
14:52
Gold makes up 16.6% of Georgia's international reserves
Region
14:49
President Ilham Aliyev and First Lady Mehriban Aliyeva attend opening of Zangilan City Education Complex
Domestic policy
14:46
President Ilham Aliyev and First Lady Mehriban Aliyeva attend inauguration of first phase of Jahangirbeyli village in Zangilan
Domestic policy
14:43
More than half of Armenians see need for snap parliamentary elections, poll finds
Region